Successful Treatment of Pure Red Cell Aplasia with Rituximab in Patients after ABO-Compatible Allogeneic Hematopoietic Stem Cell Transplantation

Pure red cell aplasia (PRCA) following allogeneic hematopoietic stem cell transplantation (HSCT) has been mostly reported in situations involving major ABO incompatibility between donor and recipient. Conventional treatments such as plasma exchange, erythropoietin, and steroid are often unsatisfacto...

Descripció completa

Dades bibliogràfiques

Autors principals:	Sung-Hoon Jung, Jae-Sook Ahn, Deok-Hwan Yang, Hyung Chul Park, Soo-Young Bae, Yeo-Kyeoung Kim, Hyeoung-Joon Kim, Je-Jung Lee
Format:	Artigo
Idioma:	Inglês
Publicat:	Karger Publishers 2012-02-01
Col·lecció:	Case Reports in Oncology
Matèries:	Rituximab ABO compatibility Pure red cell aplasia Allogeneic stem cell transplantation
Accés en línia:	http://www.karger.com/Article/FullText/337022
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!